Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials - Harrison, S A; Wong, V W; Okanoue, T; STELLAR-3; STELLAR-4 Investigators (J Hepatol, 2020)